Advertisement

Updates in Surgery

, Volume 71, Issue 4, pp 625–630 | Cite as

Fungal microbiome in colorectal cancer: a systematic review

  • Arun Anandakumar
  • Gianluca PellinoEmail author
  • Paris Tekkis
  • Christos Kontovounisios
Review Article

Abstract

Colorectal cancer (CRC) is the third cause of cancer-related death worldwide. It has been estimated that more than one million new cases occur every year. Several studies have investigated the role of host bacteria as agents protecting against or increasing the risk of CRC, but few have assessed the fungal microbiome in patients with CRC. Fungal dysbiosis has been studied in colorectal diseases (e.g. inflammatory bowel diseases), but few researches compared the fungal microbiome of CRC patients with those of controls. The current study represents a systematic review aimed at assessing the expression and diversity of fungi in patients with CRC and non-CRC individuals. Here, we discuss the fungal species that could be implied in CRC development and alterations that can be induced by the presence of CRC, and the potential implications for future research.

Keywords

Colorectal cancer Treatment Diagnosis Biomarkers Fungal microbiome Fungi 

Notes

Acknowledgements

The authors wish to thank the Royal Marsden Hospital Biomedical Research Council (BRC) for their support.

Funding

All authors have no source of funding.

Compliance with ethical standards

Conflict of interest

All authors have no conflict of interest.

Research involving human participants and/or animals

The authors did not perform any procedures on patients in this manuscript (review).

Informed consent

For this type of study, no informed consent was needed.

Supplementary material

13304_2019_683_MOESM1_ESM.doc (64 kb)
Supplementary material 1 (DOC 64 kb)

References

  1. 1.
    Brody H (2015) Colorectal cancer. Nature 521:S1CrossRefGoogle Scholar
  2. 2.
    Brenner H, Kloor M, Pox CP (2014) Colorectal cancer. Lancet 383:1490–1502CrossRefGoogle Scholar
  3. 3.
    Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424CrossRefGoogle Scholar
  4. 4.
    Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66:683–691CrossRefGoogle Scholar
  5. 5.
    Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, Cosnes J, Seksik P, Langella P, Skurnik D, Richard ML, Beaugerie L (2017) Fungal microbiota dysbiosis in IBD. Gut 66:1039–1048CrossRefGoogle Scholar
  6. 6.
    Gagnière J, Raisch J, Veziant J, Barnich N, Bonnet R, Buc E, Bringer MA, Pezet D, Bonnet M (2016) Gut microbiota imbalance and colorectal cancer. World J Gastroenterol 22:501–518CrossRefGoogle Scholar
  7. 7.
    Torisu M, Hayashi Y, Ishimitsu T, Fujimura T, Iwasaki K, Katano M, Yamamoto H, Kimura Y, Takesue M, Kondo M, Nomodo K (1990) Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother 31:261–268CrossRefGoogle Scholar
  8. 8.
    Barteneva NS, Baiken Y, Fasler-Kan E, Alibek K, Wang S, Maltsev N, Ponomarev ED, Sautbayeva Z, Kauanova S, Moore A, Beglinger C, Vorobjev IA (2017) Extracellular vesicles in gastrointestinal cancer in conjunction with microbiota: on the border of Kingdoms. Biochim Biophys Acta Rev Cancer 1868:372–393CrossRefGoogle Scholar
  9. 9.
    Glinka P, Nowacka K, Kulesza K, Ejdys E, Dynowska M (2018) Share of the Saccharomyces genus in the mycobiota of the gastrointestinal tract of oncology patients—potential effects of a fruit-based diet. Ann Parasitol 64:199–202PubMedGoogle Scholar
  10. 10.
    Luan C, Xie L, Yang X, Miao H, Lv N, Zhang R, Xiao X, Hu Y, Liu Y, Wu N, Zhu Y, Zhu B (2015) Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas. Sci Rep 5:7980CrossRefGoogle Scholar
  11. 11.
    Gao R, Kong C, Li H, Huang L, Qu X, Qin N, Qin H (2017) Dysbiosis signature of mycobiota in colon polyp and colorectal cancer. Eur J Clin Microbiol Infect Dis 36:2457–2468CrossRefGoogle Scholar
  12. 12.
    Coker OO, Nakatsu G, Dai RZ, Wu WKK, Wong SH, Ng SC, Chan FKL, Sung JJY, Yu J (2019) Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer. Gut 68:654–662CrossRefGoogle Scholar
  13. 13.
    Richard ML, Liguori G, Lamas B, Brandi G, da Costa G, Hoffmann TW, Pierluigi Di Simone M, Calabrese C, Poggioli G, Langella P, Campieri M, Sokol H (2018) Mucosa-associated microbiota dysbiosis in colitis associated cancer. Gut Microbes 9:131–142CrossRefGoogle Scholar
  14. 14.
    Li J, Chen D, Yu B, He J, Zheng P, Mao X, Yu J, Luo J, Tian G, Huang Z, Luo Y (2018) Fungi in gastrointestinal tracts of human and mice: from community to functions. Microb Ecol 75:821–829CrossRefGoogle Scholar
  15. 15.
    Hallen-Adams HE, Suhr MJ (2017) Fungi in the healthy human gastrointestinal tract. Virulence 8:352–358CrossRefGoogle Scholar

Copyright information

© Italian Society of Surgery (SIC) 2019

Authors and Affiliations

  1. 1.Department of Colorectal SurgeryChelsea and Westminster HospitalLondonUK
  2. 2.Department of Advanced Medical and Surgical SciencesUniversità degli Studi della Campania “Luigi Vanvitelli”NaplesItaly
  3. 3.Department of Colorectal SurgeryRoyal Marsden HospitalLondonUK
  4. 4.Department of Surgery and CancerImperial CollegeLondonUK

Personalised recommendations